Search Within

Department of Medicine

Formats
  1. Journal Article (19590)
  2. Meeting Abstract (16038)
  3. Review (1149)
  4. Book Section (934)
  5. Editorial (607)
  6. Research Letter (314)
  7. Conference Paper (301)
  8. Guidelines (295)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22319)
  2. Hematologic Malignancies, Division of (13274)
  3. Center for Hematologic Malignancies (11058)
  4. GSK Faculty (10645)
  5. Survivorship Research (9329)
  6. Division of Subspecialty Medicine (7534)

More Groups

People
  1. Robert Motzer (1248)
  2. Howard Scher (1132)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (905)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1064)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4215)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2286)
  6. Nature Publishing Group (2110)

More Publishers

Results (39615)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Machine learning in cancer-associated thrombosis: Hype or hope in untangling the clot
    Review

    Patell, R.; Zwicker, J. I.; Singh, R.; Mantha, S.
    Bleeding, Thrombosis and Vascular Biology (2024)

    Fulltext@MSK | Save
  • Clinical challenges in breast care for patients with PTEN pathogenic variants: A case series and literature review
    Journal Article

    Williams, A. D.; LaRoy, J.; Le, T.; Mangino, D. A.; Robson, M. E.; Heerdt, A. S.; Moo, T. A.
    Surgical Oncology Insight (2024)

    Fulltext@MSK | Save
  • Comparative efficacy of PD-1 blockade in patients with dMMR/MSI-H metastatic colorectal or gastric cancer: A global retrospective study
    Journal Article

    Mazzoli, G.; Nichetti, F.; Shitara, K.; Cohen, R.; Lonardi, S.; Cremolini, C.; Elez, M. E.; Chao, J.; Fakih, M.; Klempner, S. J.; more...
    ESMO Gastrointestinal Oncology (2024)

    Fulltext@MSK | Save
  • A phase 1 study of avapritinib in combination with decitabine in patients with systemic mastocytosis with an associated hematologic neoplasm
    Meeting Abstract

    Kuykendall, A. T.; Ball, S.; Gotlib, J.; Yi, C. Y. A.; Tashi, T.; Rampal, R.; DeAngelo, D. J.; Volpe, V. O.; Pettit, K. M.; Hoehn, G.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • CTEP 10590, NORM: Nodular lymphocyte predominant Hodgkin lymphoma patients treated in a randomized phase II trial with either rituximab or mosunetuzumab
    Meeting Abstract

    Steiner, R.; Bock, A. M.; Herrera, A. F.; Zulfa, O.; Hoffmann, M.; Ibrahimi, S.; Galanina, N.; Lee, H. J.; Green, M.; Lin, R.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Phase 3, randomized, open-label study of epcoritamab plus lenalidomide compared with rituximab plus gemcitabine and oxaliplatin in patients with relapsed or refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Ozcan, M.; Kim, W. S.; Zhang, H.; Bouzani, M.; Nagy, Z.; Chuah, H.; Salles, G.; Jeng, E. E.; Huang, J.; Sacchi, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • A multi-site break through cancer trial: Phase II study investigating dual inhibition of BCL2 and menin in AML MRD using the combination of venetoclax and revumenib (trial in progress)
    Meeting Abstract

    Issa, G. C.; Ambinder, A. J.; Xiao, W.; Manalis, S.; Shalek, A. K.; Gondek, L. P.; Kentsis, A.; Short, N. J.; Daver, N.; Ning, J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • OPTIMIZE: A phase II study of reduced dose post transplantation cyclophosphamide as GVHD prophylaxis in adult patients with hematologic malignancies receiving HLA-mismatched unrelated donor peripheral blood stem cell transplantation
    Meeting Abstract

    Auletta, J. J.; Devine, S. M.; Stefanski, H. E.; Spellman, S. R.; Defor, T. E.; Logan, B. R.; Butler, B. J.; Gooptu, M.; Shaffer, B. C.; Jimenez, A. M. J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • CD38-SADA pretargeted radioimmunotherapy (PRIT) with Lutetium 177 (Lu177)-DOTA in adult patients with relapsed or refractory non-Hodgkin lymphoma: A first-in-human phase 1 trial
    Meeting Abstract

    Zain, J.; Wong, J.; Horwitz, S.; Pandit-Taskar, N.; Al-Janadi, A.; Mancini, B.; Khawaja, R.; Lee, C. Y.; Howansky, A.; Liles, D.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Results from the Great Britain AML real world evidence (ARC) initiative - A centre-based chart review study to assess treatment outcomes of venetoclax for the treatment of acute myeloid leukemia
    Meeting Abstract

    O'Nions, J.; Errico, G.; Floro, L.; Murthy, V.; Sweeney, C.; Kaur, H.; Mohite, U.; Ayto, R.; Alvares, C.; Goldberg, A. D.; more...
    Blood (2024)

    Fulltext@MSK | Save